CVE-2023-20223
A vulnerability in Cisco DNA Center could allow an unauthenticated, remote attacker to read and...
A vulnerability in Cisco DNA Center could allow an unauthenticated, remote attacker to read and modify data in a repository that belongs to an internal service on an affected device. This vulnerability is due to insufficient access control enforcement on API requests. An attacker could exploit this vulnerability by sending a crafted API request to an affected device. A successful exploit could allow the attacker to read and modify data that is handled by an internal service on the affected device.
Attack profile
How easy it is to exploit
- Attack vector
- Network
- Complexity
- Low
- Privileges needed
- None
- User interaction
- None
What an attacker can affect
- Confidentiality
- High
- Integrity
- Low
- Availability
- Low
Exploit likelihood
What each source reports
CVE List Score used
8.6
A vulnerability in Cisco DNA Center could allow an unauthenticated, remote attacker to read and modify data in a repository that belongs to an internal service on an affected device. This vulnerability is due to insufficient access control enforcement on API requests. An attacker could exploit this vulnerability by sending a crafted API request to an affected device. A successful exploit could allow the attacker to read and modify data that is handled by an internal service on the affected device.
- Record
CVE-2023-20223- CVSS 3.1
- 8.6 High
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:L/A:L - Weakness
- CWE-284
- Updated
- 2026-11-02
EUVDEUVD-2023-24402
8.6
A vulnerability in Cisco DNA Center could allow an unauthenticated, remote attacker to read and modify data in a repository that belongs to an internal service on an affected device. This vulnerability is due to insufficient access control enforcement on API requests. An attacker could exploit this vulnerability by sending a crafted API request to an affected device. A successful exploit could allow the attacker to read and modify data that is handled by an internal service on the affected device.
- Record
EUVD-2023-24402- CVSS 3.1
- 8.6 High
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:L/A:L - Updated
- 2026-11-03
GitHub AdvisoriesGHSA-g63p-vxrj-44x5
8.6
A vulnerability in Cisco DNA Center could allow an unauthenticated, remote attacker to read and...
A vulnerability in Cisco DNA Center could allow an unauthenticated, remote attacker to read and modify data in a repository that belongs to an internal service on an affected device.
This vulnerability is due to insufficient access control enforcement on API requests. An attacker could exploit this vulnerability by sending a crafted API request to an affected device. A successful exploit could allow the attacker to read and modify data that is handled by an internal service on the affected device.
- Record
GHSA-g63p-vxrj-44x5- CVSS 3.1
- 8.6 High
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:L/A:L - Weakness
- CWE-284
- Updated
- 2026-11-02
NVD
8.6
A vulnerability in Cisco DNA Center could allow an unauthenticated, remote attacker to read and modify data in a repository that belongs to an internal service on an affected device. This vulnerability is due to insufficient access control enforcement on API requests. An attacker could exploit this vulnerability by sending a crafted API request to an affected device. A successful exploit could allow the attacker to read and modify data that is handled by an internal service on the affected device.
- Record
CVE-2023-20223- CVSS 3.1
- 8.6 High
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:L/A:L - CVSS 3.1
- 8.2 High
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:L/A:N - Weakness
- CWE-284
- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases, published | EUVD | |
| first indexed | CVE List, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2023-20223 is a high vulnerability (CVSS 8.6) in Cisco Dna Center, published September 27, 2023. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 0.64%, the 50th percentile. No source names a fixed version.